Please login to the form below

Not currently logged in
Email:
Password:

Former Pfizer Incubator head joins Amarantus

Mark Benedyk previously led the Pfizer business in helping bring new medical innovations to patients

Amarantus BioScience has appointed Dr Mark Benedyk to its board of directors.

Dr Benedyk has served as a corporate adviser to the US-based biotech since 2011, supporting its research into conditions associated with neurodegeneration and apoptosis.

He currently serves as a managing partner at business consultancy Rila Partners in addition to being a member of the strategic advisory board at KemPharma and a director at the Center for Drug Research and Development Ventures.

Previous positions including serving as head of The Pfizer Incubator (TPI), a California-based business launched by Pfizer to help scientists with entrepreneurial ambitions to bring their medical innovations to patients.

Dr Benedyk has also held executive business development roles at Ascenta Therapeutics, Optimer Pharmaceuticals, Aurora Biosciences and Elan Pharmaceutical.

“I am excited to join the Amarantus board at such an important stage of the company's scientific and business development growth,” said Dr Benedyk.

“I look forward to helping the company as it advances MANF [mesencephalic astrocyte neurotrophic factor] towards the clinic for Parkinson's disease, and executes a commercial strategy for its promising clinical diagnostic tests for Parkinson's and Alzheimer's disease.”

21st March 2013

From: Sales

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Numbers, navigation, and narratives: digital storytelling in medical communications
Science and storytelling aren’t often seen as compatible. One is based on cold, hard facts, while the other is synonymous with improvisation and theater. However, when done well, storytelling can...
Is this common data mistake killing your digital patient recruitment?
Without realising, you could be falling into the trap of using social data — insights into recent, relevant trends and topics — to inspire your content. Hold up. That sounds...
Dr Henry Skinner
The AMR Action Fund is combating antimicrobial resistance, but much more action is needed
By Henry Skinner, Chief Executive Officer of the AMR Action Fund...